1Amman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guide- lines for the management of patients with ST-elevation myocardial infarction executive Summary. Circulation ,2004,110:588-636.
3Wenzel V, Russo S, Arntz HR, et al. The new 2005 resuscitation guidelines of the European Resuscitation council: Comments and Supplements. Anaesthesist ,2006,55 ( 9 ) :958-979.
1Al-Khatib SM,Pieper KS,Lee KL,et al.Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation:results from the PURSUIT trial[J].Am J Cardiol,2001,88 (1):76-79.
2Meng F,Yoshikawa T,Baba A,et al.Beta-blockers are effective in congestive heart failure patients with atrial fibrillation[J].J Card Fail,2003,9:398-403.
3Brignole M,Menozzi C,Gasparini M,et al.An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation[J].Eur Heart J,2002,23(11):892-900.
4Van-Gelder IC,Hagens VE,Bosker HA,et al.A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation[J].N Engl J Med,2002,347(23):1 834-1 840.
5Carlsson J,Miketic S,Windeler J,et al.Randomized trial of rate-control in persistent atrial fibrillation:the Strategies of Treatment of Atrial Fibrillation(STAF)study[J].J Am Coll Cardiol,2003,41:1 690-1 696.
6Wyse DG,Waldo AL,Dimacro JP,et al.A comparison of rate control and patients with atrial fibrillation[J].N Engl J Med,2002,347 (23):1 825-1 833.
8Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary[J].Can J Cardiol,2004,20(10):977-1 025.
9Singh BN,Singh SN,Reda DJ,et al.Amiodarone versus sotalol for atrial fibrillation[J].N Engl J Med,2005,352(24):1 861-1 872.
10Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Europ Heart J,2001,22:1852-1923.
4Hirasawa Y, Nakagomi A, Kobyashi Y, et al. Short-term ami- odarone treat, ment attenuates the production of monocyte cy- tokines and chemokines byC-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomy- opathy and ventricular taehyeardia[ J]. Circ J,2009,73 (4) : 639-646.
